Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals’ risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one ...
Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one ...
New research finds that benefit extends to at least one type of non-statin cholesterol drug, called cholesterol absorption inhibitors Other non-statin cholesterol-lowering medications showed no such ...
ANN ARBOR, Mich., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that bempedoic acid (NEXLETOL ®) is now recommended as an important oral non-statin therapy for ...
A recent breakthrough study has uncovered a promising link between non-statin cholesterol-lowering medications and liver cancer prevention. Among the drugs examined, ezetimibe—commonly known by its ...
CLEVELAND, Ohio—Thanks to a little help from artificial intelligence, patients who could benefit from cholesterol-lowering drugs known as statins may be able to safely take them without a prescription ...
A new study confirms a protective effect of statin cholesterol-lowering drugs on liver cancer risk and suggests a similar effect with nonstatin cholesterol absorption inhibitors. Ever use of ...
Money Talks News on MSN
Reducing this type of cholesterol may lower dementia risk by 80%. Have you even heard of it?
The reduction in risk is potentially significant. Lowering the amount of cholesterol in the blood by a mere 1 millimole per ...
Millions of people take statins like Simvastatin (above) to lower their cholesterol levels. Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart ...
Elevated serum cholesterol is a major heart disease risk factor. There can be a genetic link responsible for high cholesterol, but for the vast majority of us, lifestyle and diet will be the key ...
LONDON, April 26 (Reuters) - Cholesterol-lowering statin drugs may protect men against prostate cancer and other urological complaints, as well as reducing the risk of heart attacks, U.S. researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results